SA Competition Commission Investigates Insulin Pen Manufacturers
The South African Competition Commission has launched an investigation into insulin pen manufacturers Novo Nordisk and Sanofi Aventis. According to the Health Justice Initiative (HJI), the probe aims to determine whether multiple device patents and proprietary designs for insulin pens and cartridges are being used to stifle competition and block alternative suppliers from entering the market.